Celastrol (CEL), a potent leptin sensitizer, has been studied for the treatment of MASLD; however, its clinical application is hindered by its low oral bioavailabilities and high toxicities. The gene discussed is LEP; the disease is metabolic dysfunction-associated steatotic liver disease.